gold(iii) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1...

48
1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors and antiproliferative agents Brech Aikman, 1, † Margot N. Wenzel, 1, † Andreia Mosca, 2, † Wim T. Klooster, 3 Simon J. Coles, 3 Andreia de Almeida, 1 Graça Soveral, 2, * Angela Casini 1, *

Upload: others

Post on 10-Mar-2021

7 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

1

Supporting Information

Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors and antiproliferative agents

Brech Aikman,1, † Margot N. Wenzel,1, † Andreia Mosca,2, † Wim T. Klooster,3 Simon J. Coles,3 Andreia de Almeida, 1 Graça Soveral,2,* Angela Casini 1,*

Page 2: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

2

Scheme S1. Synthetic pathways to ligands L1-L12.

HN

NN

DMF, r.t., 4 h

N

NN

L1(80 %)

R = Methyl, X = I

N

NN

N

NN

N

NN

N

NN

CO2Me

N

NN

CF3

N

NN

F

N

NN

FF

F

F

F

N

NN

F

F

+ R-X, K2CO3

L2(75 %)

R = Ethyl, X = I

L3(50 %)

R = Octyl, X = Br

L4(79 %)

R = Benzyl, X = Br

L5(83 %)

R = 4-methylbenzoate, X = Br

L6(88 %)

R = 4-trifluoromethylbenzyl, X = Br

L7(99 %)

R = 4-fluorobenzyl, X = Br

L8(85 %)

R = pentafluorobenzyl, X = Br

L9(88 %)

R = 3,5-difluorobenzyl, X = Br

O

O+ N

CHO NH4OAc

AcOH, EtOH/DCMreflux, 3 h

N

HN N

L11(87 %)

O

O

+ N

CHO

NH4OAc

AcOH, EtOH/DCMreflux, 3 h

N

HN N

NaIO4RuCl3 cat.

DCM/MeCN/DCMr.t., 24 h

(42 %) L12(99 %)

L10

Page 3: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

3

S1. NMR spectra Ligand L5

• 1H NMR:

Figure S1. 1H NMR (400.13 MHz, CDCl3) spectrum of ligand L5.

• 13C{1H} NMR:

Figure S2. 13C{1H} NMR (100.61 MHz, CDCl3) spectrum of ligand L5.

[ppm] 9 8 7 6 5 4

7.89

757.

8931

7.88

047.

8780

7.87

597.

8609

7.85

847.

8560

7.83

577.

8312

7.81

607.

8115

7.79

677.

7922

7.33

227.

3269

7.31

657.

3114

7.30

737.

3044

7.29

547.

2917

7.28

867.

2855

7.27

637.

2728

7.26

997.

2599

7.25

727.

2540

7.24

967.

2368

7.23

397.

2154

7.19

42

6.22

22

3.90

103.

8480

1.00

140.

9898

2.03

381.

0245

1.01

28

4.47

841.

9965

1.96

97

3.00

00

Unsigned

400_MNW185_Sergio_F2_CDCl3 10 1 "C:\Users\Stone\Desktop\NMR Margot"

[ppm] 160 140 120 100 80 60 40

166.

8180

150.

3835

149.

8802

148.

6676

142.

7956

142.

7818

137.

0109

136.

7736

129.

9897

129.

3100

126.

7391

124.

6720

124.

0378

123.

8538

123.

0902

120.

3374

110.

5222

77.4

748

77.1

570

76.8

392

52.1

746

48.9

125

Unsigned

400_MNW185_Sergio_F2_CDCl3 21 1 "C:\Users\Stone\Desktop\NMR Margot"

Page 4: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

4

Ligand L6 • 1H NMR:

Figure S3. 1H NMR (400.14 MHz, CDCl3) spectrum of ligand L6.

• 13C{1H} NMR:

Figure S4. 13C{1H} NMR (100.61 MHz, CDCl3) spectrum of ligand L6.

[ppm] 8 6 4 2

7.85

807.

8409

7.83

847.

8144

7.80

997.

7950

7.79

067.

7754

7.77

097.

4786

7.45

827.

3122

7.30

407.

2995

7.29

147.

2853

7.28

317.

2795

7.27

127.

2669

7.26

397.

2608

7.25

887.

2512

7.24

887.

2438

7.23

867.

2353

7.22

52

6.19

82

0.18

950.

5135

1.05

510.

4979

2.28

65

6.13

66

0.18

27

Unsigned

400_MNW134_F15-25_CDCl3 10 1 "C:\Users\Stone\Desktop\NMR Margot"

[ppm] 140 120 100 80 60 40

150.

3783

149.

8399

148.

6797

142.

8268

141.

6968

141.

6847

137.

0569

136.

7288

130.

1780

129.

8558

129.

5333

129.

2105

128.

1861

127.

0943

126.

8546

125.

7145

125.

6772

125.

6396

125.

6018

125.

4821

125.

3737

125.

3355

124.

7165

124.

0911

123.

9361

123.

1725

122.

7782

120.

4143

120.

0743

110.

4462

77.4

739

77.3

591

77.1

562

76.8

385

69.6

032

64.1

149

53.8

943

48.7

174

31.8

038

29.3

641

Unsigned

400_MNW134_F15-25_CDCl3 21 1 "C:\Users\Stone\Desktop\NMR Margot"

Page 5: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

5

Complex C2 • 1H NMR:

Figure S5. 1H NMR (500.13 MHz, DMSO-d6) spectrum of complex C2.

• 13C{1H} NMR:

Figure S6. 13C{1H} NMR (125.77 MHz, DMSO-d6) spectrum of complex C2.

[ppm] 8 6 4 2

8.92

71

8.28

858.

2752

8.21

408.

2019

8.05

598.

0432

7.88

867.

8756

7.75

457.

6131

4.87

704.

8651

2.49

85

2.06

94

1.50

06

1.00

00

1.05

180.

9990

1.00

841.

0729

1.02

622.

0478

2.00

10

2.96

59

Unsigned

500_MNW016_DMSO 10 1 "C:\Users\Stone\Desktop\NMR Margot"

[ppm] 140 120 100 80 60 40 20

151.

0806

150.

1984

146.

8117

144.

2941

138.

3893

138.

2205

133.

3010

127.

9952

127.

5432

127.

3262

126.

6156

126.

0524

125.

8235

115.

7997

114.

4258

113.

8296

112.

8589

41.3

774

40.1

058

40.0

151

39.9

391

39.8

482

39.7

720

39.6

813

39.6

063

39.5

144

39.3

474

39.1

805

39.0

136

14.8

599

Unsigned

500_MNW016_DMSO 11 1 "C:\Users\Stone\Desktop\NMR Margot"

Page 6: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

6

Complex C3

• 1H NMR:

Figure S7. 1H NMR (400.13 MHz, DMSO-d6) spectrum of complex C3.

• 13C{1H} NMR:

Figure S8. 13C{1H} NMR (125.77 MHz, DMSO-d6) spectrum of complex C3.

[ppm] 8 6 4 2

8.27

718.

2583

8.25

538.

2387

8.23

528.

1368

8.13

228.

1235

8.11

507.

9273

7.91

837.

9105

7.90

527.

8173

7.81

367.

8012

7.78

747.

7030

7.68

867.

6839

7.67

437.

6648

7.66

057.

6459

4.88

294.

8644

4.84

55

3.46

123.

4437

3.42

633.

4088

2.50

462.

5004

2.49

621.

8880

1.87

011.

8524

1.83

321.

3095

1.29

171.

2736

1.26

601.

2472

1.23

171.

2133

1.18

561.

0673

1.04

991.

0324

0.84

440.

8276

0.80

98

1.00

00

2.09

861.

0139

1.04

441.

0278

2.11

39

2.25

43

2.09

58

10.8

713

3.16

13

Unsigned

400_MNW171_DMSO 20 1 "C:\Users\Stone\Desktop\NMR Margot"

[ppm] 160 140 120 100 80 60 40 20

150.

5001

M 1

47.0

059

M 1

43.7

077

138.

6059

M 1

36.6

401

133.

4102

127.

2487

126.

4716

126.

3323

M 1

15.6

729

M 1

14.7

306

113.

5855

46.0

517

31.3

548

28.6

918

28.5

497

25.9

980

22.2

776

14.1

810

Unsigned

300_MNW011_DMSO 3 1 "C:\Users\Stone\Desktop\NMR Margot"

Page 7: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

7

Complex C4

• 1H NMR:

Figure S9. 1H NMR (400.13 MHz, DMSO-d6) spectrum of complex C4.

• 13C{1H} NMR:

Figure S10. 13C{1H} NMR (125.77 MHz, DMSO-d6) spectrum of complex C4.

[ppm] 8 6 4 2

8.15

308.

1490

7.88

977.

8871

7.86

917.

8199

7.80

117.

7181

7.70

607.

7008

7.68

867.

5808

7.57

837.

5630

7.56

037.

5443

7.54

027.

5239

7.52

147.

5059

7.28

937.

2699

7.26

777.

2559

7.24

477.

2408

7.23

307.

2233

6.18

98

3.40

043.

3829

2.46

012.

4558

2.45

14

2.02

62

1.02

341.

0059

0.98

84

1.00

00

1.05

151.

0825

1.13

451.

1720

1.20

132.

4561

5.52

83

2.06

38

Unsigned

400_MNW170_DMSO 20 1 "C:\Users\Stone\Desktop\NMR Margot"

[ppm] 140 120 100 80 60 40

150.

1873

147.

5438

144.

7707

138.

4455

135.

8286

134.

0921

128.

8996

128.

0519

127.

2052

126.

8099

126.

1327

126.

0269

125.

9860

116.

3915

113.

3022

48.9

726

40.2

918

40.2

012

40.1

252

40.0

343

39.9

577

39.8

673

39.7

908

39.7

004

39.6

259

39.5

334

39.3

665

39.1

995

Unsigned

500_MNW062_DMSO 11 1 "C:\Users\Stone\Desktop\NMR Margot"

Page 8: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

8

Complex C5

• 1H NMR:

Figure S11. 1H NMR (400.13 MHz, DMSO-d6) spectrum of complex C5.

• 13C{1H} NMR:

Figure S12. 13C{1H} NMR (100.61 MHz, DMSO-d6) spectrum of complex C5.

[ppm] 8 6 4 2

8.18

667.

9142

7.90

547.

8847

7.58

147.

5590

7.53

777.

4234

7.40

28

6.30

44

4.32

07

3.81

30

2.51

142.

5071

2.50

28

1.71

56

1.73

441.

9441

9.47

37

3.88

293.

8059

3.59

73

46.0

820

27.5

006

0.26

35

Unsigned

400_MNW188_DMSO 11 1 "C:\Users\Stone\Desktop\NMR Margot"

[ppm] 140 120 100 80 60 40

149.

9477

141.

2909

138.

2913

129.

5467

129.

0524

127.

2591

126.

6116

125.

9374

125.

7181

116.

4591

112.

9213

52.2

270

48.8

173

40.1

359

39.9

272

39.7

184

39.5

097

39.3

009

39.0

923

38.8

836

Unsigned

400_MNW188_DMSO 12 1 "C:\Users\Stone\Desktop\NMR Margot"

Page 9: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

9

Complex C6

• 1H NMR:

Figure S13. 1H NMR (400.13 MHz, DMSO-d6) spectrum of complex C6.

• 13C{1H} NMR:

Figure S14. 13C{1H} NMR (100.61 MHz, DMSO-d6) spectrum of complex C6.

[ppm] 8 6 4 2

8.83

668.

3376

8.31

798.

2469

8.24

468.

2276

8.20

837.

9629

7.94

327.

8525

7.83

277.

7600

7.74

727.

7423

7.72

897.

7161

7.69

577.

6507

7.63

327.

6089

7.58

727.

5571

7.53

69

6.32

63

3.46

763.

4501

3.43

263.

4152

3.40

063.

3831

3.36

563.

3482

2.50

65

2.07

21

1.09

991.

0824

1.07

081.

0650

1.05

341.

0360

3.62

67

7.51

41

34.4

341

27.4

243

3.21

75

15.3

948

3.58

21

4.80

63

Unsigned

400_MNW166_DMSO 20 1 "C:\Users\Stone\Desktop\NMR Margot"

[ppm] 140 120 100 80 60 40

150.

1647

147.

2815

143.

8777

140.

3409

138.

4549

133.

6404

132.

8823

128.

6171

128.

2996

127.

9819

127.

8611

126.

9966

126.

5644

126.

3819

125.

9863

125.

6619

125.

6247

125.

4697

122.

7654

118.

1375

115.

9054

113.

1966

64.9

761

56.0

839

48.7

609

40.1

419

39.9

330

39.7

243

39.5

155

39.3

068

39.0

981

38.8

896

Unsigned

400_MNW166_DMSO 21 1 "C:\Users\Stone\Desktop\NMR Margot"

Page 10: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

10

Complex C7

• 1H NMR:

Figure S15. 1H NMR (400.13 MHz, DMSO-d6) spectrum of complex C7.

• 13C{1H} NMR:

Figure S16. 13C{1H} NMR (100.61 MHz, DMSO-d6) spectrum of complex C7.

[ppm] 8 6 4 2

7.83

517.

8308

7.75

427.

7518

7.74

227.

7397

7.73

527.

7328

7.72

317.

7207

7.58

447.

5806

7.57

297.

5672

7.56

137.

5534

7.54

967.

4028

7.39

787.

3892

7.38

107.

3726

7.36

747.

1782

7.17

297.

1612

7.15

607.

1505

7.13

897.

1338

6.20

49

4.79

814.

7937

3.46

973.

4522

3.43

473.

4172

2.52

532.

5167

2.51

222.

5077

2.50

312.

4987

2.07

79

1.07

511.

0576

1.04

01

2.71

87

2.75

592.

7787

8.42

05

5.60

645.

5846

5.62

75

5.56

70

28.6

978

2.29

68

0.22

8324

.147

80.

1365

2.15

70

3.27

65

Unsigned

400_MNW167_DMSO 11 1 "C:\Users\Stone\Desktop\NMR Margot"

[ppm] 160 140 120 100 80 60 40 20

162.

8980

160.

4713

150.

0361

147.

3699

144.

6423

138.

3375

133.

9754

133.

8678

131.

9685

131.

9383

129.

4409

129.

3578

126.

6861

126.

0043

125.

9079

125.

8645

116.

2849

115.

6875

115.

4730

113.

1059

56.0

596

48.1

797

40.1

409

39.9

323

39.7

235

39.5

148

39.3

060

39.0

974

38.8

886

Unsigned

400_MNW167_DMSO 12 1 "C:\Users\Stone\Desktop\NMR Margot"

Page 11: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

11

Complex C8

• 1H NMR:

Figure S17. 1H NMR (400.13 MHz, DMSO-d6) spectrum of complex C8.

• 13C{1H} NMR:

Figure S18. 13C{1H} NMR (100.61 MHz, DMSO-d6) spectrum of complex C8.

[ppm] 8 6 4 2

8.76

498.

7540

8.32

228.

3024

8.16

098.

1570

8.14

148.

1375

8.12

198.

1179

7.90

037.

8753

7.85

517.

6804

7.66

817.

6629

7.65

057.

5844

7.56

827.

5493

7.54

417.

5402

7.52

157.

5051

6.68

53

6.35

64

3.44

303.

4255

3.40

803.

3905

2.48

802.

4838

2.47

96

2.05

23

1.04

801.

0306

1.01

31

1.00

00

1.00

711.

0323

2.05

75

1.04

382.

0945

4.31

67

2.04

27

Unsigned

400_MNW168_DMSO 20 1 "C:\Users\Stone\Desktop\NMR Margot"

[ppm] 160 140 120 100 80 60 40 20

149.

3447

147.

9380

145.

5504

143.

6952

138.

2466

135.

7169

135.

2411

134.

5750

126.

2919

125.

6862

125.

4496

125.

3731

117.

0565

112.

3258

110.

5744

110.

4065

110.

2374

56.0

682

40.1

466

39.9

380

39.7

294

39.5

206

39.3

119

39.1

031

38.8

947

18.6

008

Unsigned

400_MNW168_DMSO 21 1 "C:\Users\Stone\Desktop\NMR Margot"

Page 12: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

12

Complex C9

• 1H NMR:

Figure S19. 1H NMR (400.13 MHz, DMSO-d6) spectrum of complex C9.

• 13C{1H} NMR:

Figure S20. 13C{1H} NMR (100.61 MHz, DMSO-d6) spectrum of complex C9.

[ppm] 8 6 4 2

8.87

118.

8637

8.33

738.

3180

8.26

648.

2472

8.22

807.

9664

7.94

717.

8413

7.82

187.

7804

7.76

737.

7524

7.66

647.

6487

7.62

607.

6038

7.58

557.

2153

7.19

227.

1626

7.14

46

6.40

326.

2765

6.22

37

3.46

633.

4489

3.43

153.

4141

2.50

76

1.07

121.

0538

1.03

64

3.18

34

6.55

30

16.9

443

41.9

482

3.34

21

23.0

105

5.01

85

Unsigned

400_MNW169_DMSO 11 1 "C:\Users\Stone\Desktop\NMR Margot"

[ppm] 160 140 120 100 80 60 40

164.

2329

164.

1003

161.

7803

161.

6483

150.

6248

147.

6548

144.

0558

140.

3492

140.

2559

138.

9144

133.

8476

132.

8492

127.

5278

127.

1303

126.

9000

126.

5247

116.

0970

113.

6575

111.

1586

111.

0873

110.

9676

110.

8981

104.

2199

103.

9644

103.

7038

56.4

971

48.9

284

42.0

079

41.7

989

41.5

952

40.5

658

40.3

571

40.1

485

39.9

398

39.7

311

39.5

224

39.3

140

19.0

338

Unsigned

400_MNW169_DMSO 12 1 "C:\Users\Stone\Desktop\NMR Margot"

Page 13: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

13

Complex 11

• 1H NMR:

Figure S21. 1H NMR (500.17 MHz, DMSO-d6) spectrum of complex C11.

• 13C{1H} NMR:

Figure S22. 13C{1H} NMR (125.77 MHz, DMSO-d6) spectrum of complex C11.

[ppm] 8 6 4 2

8.49

018.

4752

8.45

968.

3949

8.37

958.

2124

8.19

758.

1823

8.13

198.

1166

8.10

137.

8577

7.84

637.

8310

7.81

417.

7999

7.77

087.

7545

7.73

987.

6955

7.68

477.

6714

7.66

017.

6474

2.49

89

8.35

112.

0000

4.55

071.

8051

1.07

211.

8542

11.3

478

3.06

79

Unsigned

500_MNW065_DMSO 20 1 "C:\Users\Stone\Desktop\NMR Margot"

[ppm] 160 140 120 100 80 60 40

160.

7991

150.

2904

150.

0458

145.

3659

145.

0359

138.

6149

138.

0315

134.

8577

129.

3120

128.

7910

128.

2665

128.

1904

127.

6005

127.

4561

127.

0045

126.

0343

125.

4565

124.

5542

124.

4446

124.

3738

123.

3601

122.

7367

122.

4539

120.

9828

120.

3637

Unsigned

400_MNW086_DMSO 12 1 "C:\Users\Stone\Desktop\NMR Margot"

Page 14: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

14

Complex 12

• 1H NMR:

Figure S23. 1H NMR (500.17 MHz, MeCN-d3) spectrum of complex C12.

• 13C{1H} NMR:

Figure S24. 13C{1H} NMR (125.77 MHz, DMSO-d6) spectrum of complex C12.

[ppm] 8 6 4 2

8.63

058.

5617

8.54

688.

4835

8.46

858.

3563

8.34

098.

2887

8.27

548.

2464

8.23

198.

2067

8.14

478.

1326

8.10

598.

0573

8.04

398.

0300

8.01

397.

9831

7.58

547.

5740

2.49

752.

4556

2.44

49

1.92

98

Unsigned

500_MNW064_ACN 10 1 "C:\Users\Stone\Desktop\NMR Margot"

[ppm] 160 140 120 100 80 60

161.

1558

150.

4087

149.

5927

148.

5808

145.

6814

145.

4708

137.

9382

135.

6130

131.

6791

128.

3194

127.

8396

127.

8028

127.

1500

126.

6209

126.

3059

126.

0630

125.

9381

125.

0142

124.

5561

123.

4077

122.

8085

122.

5806

122.

2357

121.

6890

119.

9770

119.

7313

119.

5220

118.

2795

Unsigned

500_MNW064_DMSO_repeat 11 1 "C:\Users\Stone\Desktop\NMR Margot"

Page 15: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

15

S2. Photophysical properties

• Absorption and emission

Ligand L1

Quantum yield in DMSO at 298K:

60%

(Concentration: 3.3.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 311 (20260).

Figure S25: Absorption and emission spectra of ligand L1.

Complex C1

Quantum yield in DMSO at 298K:

48%

(Concentration: 3.3.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 311 (23949).

Figure S26: Absorption and emission spectra of complex C1.

0

50

100

150

200

250

300

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat321nm

0

50

100

150

200

250

300

350

400

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat315nm

Page 16: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

16

Ligand L2

Quantum yield in DMSO at 298K:

54%

(Concentration: 3.3.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 312 (21645).

Figure S27: Absorption and emission spectra of ligand L2.

Complex C2

Quantum yield in DMSO at 298K:

39% (Concentration: 3.3.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 313 (21654).

Figure S28: Absorption and emission spectra of complex C2.

Ligand L3 Quantum yield in DMSO at 298K:

50% (Concentration: 3.3.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 313 (27357).

Figure S29: Absorption and emission spectra of ligand L3.

0

50

100

150

200

250

300

350

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance

(A.U.)

Wavelength(nm)

Absorption

Emissionat319nm

0

50

100

150

200

250

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance

(A.U.)

Wavelength(nm)

Absorption

Emissionat320nm

0

50

100

150

200

250

300

350

400

0

0.2

0.4

0.6

0.8

1

1.2

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat329nm

Page 17: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

17

Complex C3

Quantum yield in DMSO at 298K:

27% (Concentration: 6.6.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 312 (16006).

Figure S30: Absorption and emission spectra of complex C3.

Ligand L4

Quantum yield in DMSO at 298K:

27%

(Concentration: 3.3.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 312 (24729).

Figure S31: Absorption and emission spectra of ligand L4.

Complex C4 Quantum yield in DMSO at 298K:

23%

(Concentration: 3.3.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 313 (21527).

Figure S32: Absorption and emission spectra of complex C4.

0

20

40

60

80

100

120

140

0

0.2

0.4

0.6

0.8

1

1.2

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat331nm

0

20

40

60

80

100

120

140

160

180

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat320nm

0

20

40

60

80

100

120

140

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat321nm

Page 18: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

18

Ligand L5 Quantum yield in DMSO at 298K:

30%

(Concentration: 4.2.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 313 (14123).

Figure S33: Absorption and emission spectra of ligand L5.

Complex C5

Quantum yield in DMSO at 298K:

29%

(Concentration: 3.4.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 312 (23448).

Figure S34: Absorption and emission spectra of complex C5.

Ligand L6

Quantum yield in DMSO at 298K:

38%

(Concentration: 3.3.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 313 (23130).

Figure S35: Absorption and emission spectra of ligand L6.

0

50

100

150

200

250

300

350

400

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat320nm

0

50

100

150

200

250

300

350

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat323nm

0

50

100

150

200

250

300

350

400

450

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat318nm

Page 19: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

19

Complex C6 Quantum yield in DMSO at 298K:

32%

(Concentration: 2.7.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 312 (24699).

Figure S36: Absorption and emission spectra of complex C6.

Ligand L7

Quantum yield in DMSO at 298K:

32%

(Concentration: 3.8.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 312 (21244).

Figure S37: Absorption and emission spectra of ligand L7.

Complex C7

Quantum yield in DMSO at 298K:

26%

(Concentration: 2.6.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 312 (25542).

Figure S38: Absorption and emission spectra of complex C7.

0

50

100

150

200

250

300

350

400

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat317nm

0

50

100

150

200

250

300

350

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat319nm

0

50

100

150

200

250

300

350

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat321nm

Page 20: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

20

Ligand L8 Quantum yield in DMSO at 298K:

42% (Concentration: 2.4.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 312 (29031).

Figure S39: Absorption and emission spectra of ligand L8.

Complex C8

Quantum yield in DMSO at 298K:

36%

(Concentration: 2.9.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 311 (23441).

Figure S40: Absorption and emission spectra of complex C8.

Ligand L9

Quantum yield in DMSO at 298K:

36%

(Concentration: 3.1.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 312 (22425).

Figure S41: Absorption and emission spectra of ligand L9.

0

50

100

150

200

250

300

350

400

450

500

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat319nm

0

50

100

150

200

250

300

350

400

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat321nm

0

50

100

150

200

250

300

350

400

450

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat319nm

Page 21: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

21

Complex C9

Quantum yield in DMSO at 298K:

30%

(Concentration: 3.0.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 313 (14367).

Figure S42: Absorption and emission spectra of complex C9.

Ligand L10

Quantum yield in DMSO at 298K:

69%

(Concentration: 3.3.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 313 (24475).

Figure S43: Absorption and emission spectra of ligand L10.

Complex C10

Quantum yield in DMSO at 298K: 4%

(Concentration: 5.0.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 328 (12883).

Figure S44: Absorption and emission spectra of complex C10.

0

50

100

150

200

250

300

350

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat321nm

0

50

100

150

200

250

300

350

400

450

0

0.2

0.4

0.6

0.8

1

1.2

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat328nm

0

10

20

30

40

50

60

70

80

90

100

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat335nm

Page 22: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

22

Ligand L11 Quantum yield in DMSO at 298K:

74%

(Concentration: 4.0.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 333 (20088), 362

(15966).

Figure S45: Absorption and emission spectra of ligand L11.

Complex C11 Quantum yield in DMSO at 298K:

56%

(Concentration: 5.6.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 333 (20891), 362

(16528).

Figure S46: Absorption and emission spectra of complex C11.

Ligand L12 Quantum yield in DMSO at 298K:

61%

(Concentration: 3.3.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 338 (25928), 353

(24139), 366 (15420), 387 (15708).

Figure S47: Absorption and emission spectra of ligand L12.

0

50

100

150

200

250

300

350

400

450

500

0

0.2

0.4

0.6

0.8

1

1.2

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat338nm

0

50

100

150

200

250

300

350

0

0.2

0.4

0.6

0.8

1

1.2

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat325nm

0

50

100

150

200

250

300

0

0.2

0.4

0.6

0.8

1

1.2

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat341nm

Page 23: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

23

Complex C12

Quantum yield in DMSO at 298K:

71%

(Concentration: 2.2.10-5M)

UV-Vis (DMSO): λmax (nm) (ε, cm-

1.mol-1.dm3) 338 (28904), 353

(28264), 366 (19892), 388 (20031).

Figure S48: Absorption and emission spectra of complex C12.

0

50

100

150

200

250

300

0

0.2

0.4

0.6

0.8

1

1.2

300 350 400 450 500 550 600 650 700 750 800

Emission(A.U.)Absorbance(A.U.)

Wavelength(nm)

Absorption

Emissionat323nm

Page 24: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

24

S3. Stability studies by UV-visible spectrophotometry

Figure S49: UV-Visible spectra of the Au(III) complex C1 (10-4 M) in PBS (pH 7.4) recorded over time (left); and of C1 before and after addition of GSH (2 eq.) recorded over time at room temperature (right).

Figure S50: UV-Visible spectra of the Au(III) complex C2 (10-4 M) in PBS (pH 7.4) recorded over time (left); and of C2 before and after addition of GSH (2 eq.) recorded over time at room temperature (right).

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

2

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

t = 24 h

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

2

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

C1

0

0.2

0.4

0.6

0.8

1

1.2

1.4

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

t = 24 h

0

0.2

0.4

0.6

0.8

1

1.2

1.4

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

t = 24 h

C2

Page 25: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

25

Figure S51: UV-Visible spectra of the Au(III) complex C3 (10-4 M) in PBS (pH 7.4) recorded over time (left); and of C3 before and after addition of GSH (2 eq.) recorded over time at room temperature (right).

Figure S52: UV-Visible spectra of the Au(III) complex C4 (10-4 M) in PBS (pH 7.4) recorded over time (left); and of C4 before and after addition of GSH (2 eq.) recorded over time at room temperature (right).

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

2

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

2

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

C3

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

t = 24 h

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

C4

Page 26: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

26

Figure S53: UV-Visible spectra of the Au(III) complex C5 (10-4 M) in PBS (pH 7.4) recorded over time (left); and of C5 before and after addition of GSH (2 eq.) recorded over time at room temperature (right).

Figure S54: UV-Visible spectra of the Au(III) complex C6 (10-4 M) in PBS (pH 7.4) recorded over time (left); and of C6 before and after addition of GSH (2 eq.) recorded over time at room temperature (right).

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

t = 24 h

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

C5

0

0.2

0.4

0.6

0.8

1

1.2

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

t = 24 h

0

0.2

0.4

0.6

0.8

1

1.2

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

C6

Page 27: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

27

Figure S55: UV-Visible spectra of the Au(III) complex C7 (10-4 M) in PBS (pH 7.4) recorded over time (left); and of C7 before and after addition of GSH (2 eq.) recorded over time at room temperature (right).

Figure S56: UV-Visible spectra of the Au(III) complex C8 (10-4 M) in PBS (pH 7.4) recorded over time (left); and of C8 before and after addition of GSH (2 eq.) recorded over time at room temperature (right).

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

2

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

t = 24 h

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

2

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

C7

0

0.5

1

1.5

2

2.5

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

t = 24 h

0

0.5

1

1.5

2

2.5

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

C8

Page 28: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

28

Figure S57: UV-Visible spectra of the Au(III) complex C9 (10-4 M) in PBS (pH 7.4) recorded over time (left); and of C9 before and after addition of GSH (2 eq.) recorded over time at room temperature (right).

Figure S58: UV-Visible spectra of the Au(III) complex C10 (10-4 M) in PBS (pH 7.4) recorded over time (left); and of C10 before and after addition of GSH (2 eq.) recorded over time at room temperature (right).

0

0.2

0.4

0.6

0.8

1

1.2

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

t = 24 h

0

0.2

0.4

0.6

0.8

1

1.2

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

C9

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

t = 24 h

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

C10

Page 29: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

29

Figure S59: UV-Visible spectra of the Au(III) complex C11 (10-4 M) in PBS (pH 7.4) recorded over time (left); and of C11 before and after addition of GSH (2 eq.) recorded over time at room temperature (right).

Figure S60: UV-Visible spectra of the Au(III) complex C12 (10-4 M) in PBS (pH 7.4) recorded over time (left); and of C12 before and after addition of GSH (2 eq.) recorded over time at room temperature (right).

0

0.2

0.4

0.6

0.8

1

1.2

1.4

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

t = 24 h

0

0.2

0.4

0.6

0.8

1

1.2

1.4

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

C11

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

t = 24 h

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

800750700650600550500450400350300

Abso

rban

ce

Wavelength (nm)

t = 0 h

t = 0.25 h

t = 0.5 h

t = 0.75 h

t = 1 h

t = 2 h

t = 3 h

t = 4 h

t = 6 h

C12

Page 30: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

30

Table S1. Antiproliferative activities (EC50 values) of ligands in human SKOV-3, A375, MCF-7, and A549 cells after 72 h incubation.

Compound EC50 [µM] 1

SKOV-3

(++) A375

(+) MCF7

(++) A549

(+) L1 >80 >80 >80 >80 L2 >80 n.d. >80 >80 L3 38 ± 12 18 ± 2 44 ± 1 44 ± 3 L4 45 ± 3 53 ± 4 55 ± 3 61 ± 5 L5 >80 (n=1) >80 (n=1) 31 (n=1) >80 (n=1) L6 36 (n=1) 26 ± 3 38 (n=1) 36 (n=2)

L7 >80 (n=1) 59 (n=1) 73 (n=1) >80 (n=1)

L8 >80 (n=1) >80 (n=1) >80 (n=1) >80 (n=1)

L9 L10

60 (n=1) >80

45 (n=1) >80

55 (n=1) >80

54 (n=1) >80

L11 >80 20 ± 2 4 ± 1 >80 L12 52 ± 21 17 (n=1) 23 ± 2 73 ± 8

1 Values represented as mean (± SEM) of at least three independent experiments (n), unless otherwise stated. n.d.= non determined.

Figure S61. Normalized mean fluorescence intensity (MFI) of AQP3, detected using a secondary Alexa Fluor®488-labelled antibody. Results were normalized for the sample with the lowest expression (A375) and results are expressed as mean ± SEM of three independent experiments. *p < 0.03.

Page 31: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

2018ncs0304

Submittedby: ProfCasini

Solvedby: WimTKlooster

SampleID: C6

CrystalDataandExperimental

Figure1:Thermalellipsoidsdrawnatthe50%probabilitylevel.

Experimental.Asuitableyellowblock-shapedcrystalsof2018ncs0304 (0.050×0.040×0.030)mm3 was selectedandmountedonaMITIGENholderinperfluoroetheroilona Rigaku 007HF diffractometer equipped with Varimaxconfocal mirrors and an AFC11 goniometer and HyPix6000HEdetector.ThecrystalwaskeptatT=100.00(10)Kduring data collection. Using Olex2 (Dolomanov et al.,2009), the structure was solved with the ShelXT(Sheldrick, 2015) structure solution program, using theIntrinsicPhasingsolutionmethod.Themodelwasrefinedwith version 2014/7 of ShelXL (Sheldrick, 2015) usingLeastSquaresminimisation.

CrystalData.C20H14Au2Cl6F3N3,Mr=959.97,triclinic,P-1(No.2),a=9.1341(3)Å,b=9.2310(3)Å,c=16.4226(5)Å,a= 78.730(3)°, b= 86.795(2)°, g= 71.093(3)°, V=1284.69(8)Å3,T=100(2)K,Z=2,Z'=1,µ(CuKa)=27.253mm-1, 23132 reflections measured, 4640 unique (Rint=0.0720)whichwereusedinallcalculations.ThefinalwR2was0.1431(alldata)andR1was0.0504(I>2(I)).

Compound 2018ncs0304 Formula C20H14Au2Cl6F3N3 Dcalc./gcm-3 2.482 µ/mm-1 27.253 FormulaWeight 959.97 Colour yellow Shape block Size/mm3 0.050×0.040×0.030 T/K 100(2) CrystalSystem triclinic SpaceGroup P-1 a/Å 9.1341(3) b/Å 9.2310(3) c/Å 16.4226(5) a/° 78.730(3) b/° 86.795(2) g/° 71.093(3) V/Å3 1284.69(8) Z 2 Z' 1 Wavelength/Å 1.54184 Radiationtype CuKa Qmin/° 2.744 Qmax/° 68.244 MeasuredRefl. 23132 IndependentRefl. 4640 ReflectionsUsed 4211 Rint 0.0720 Parameters 310 Restraints 0 LargestPeak 3.059 DeepestHole -2.835 GooF 1.058 wR2(alldata) 0.1431 wR2 0.1400 R1(alldata) 0.0543 R1 0.0504

Angela Casini
Figure S62:
Page 32: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

StructureQualityIndicators

Reflections:

Refinement:

Ayellowblock-shapedcrystalwithdimensions0.050×0.040×0.030mm3wasmountedonaMITIGENholderinperfluoroetheroil.X-raydiffractiondatawerecollectedusingaRigaku007HFdiffractometerequippedwithVarimaxconfocalmirrorsandanAFC11goniometerandHyPix6000HEdetector,andequippedwithanOxfordCryosystemslow-temperaturedevice,operatingatT=100.00(10)K.

Dataweremeasuredusingwscansof0.5°perframefor0.5susingCuKaradiation(Rotating-anodeX-raytube,40kV,30mA).ThetotalnumberofrunsandimageswasbasedonthestrategycalculationfromtheprogramCrysAlisPro(Rigaku,V1.171.39.46,2018).ThemaximumresolutionachievedwasQ=68.244°.

CellparameterswereretrievedusingtheCrysAlisPro(Rigaku,V1.171.39.46,2018)softwareandrefinedusingCrysAlisPro(Rigaku,V1.171.39.46,2018)on10414reflections,45%oftheobservedreflections.

DatareductionwasperformedusingtheCrysAlisPro(Rigaku,V1.171.39.46,2018)softwarewhichcorrectsforLorentzpolarisation.Thefinalcompletenessis99.20%outto68.244°inQ.

A multi-scan absorption correction was performed using CrysAlisPro 1.171.39.46 (Rigaku OxfordDiffraction, 2018) Empirical absorption correction using spherical harmonics, implemented in SCALE3ABSPACKscalingalgorithm.Theabsorptioncoefficientµofthismaterialis27.253mm-1atthiswavelength(l=1.54184Å)andtheminimumandmaximumtransmissionsare0.12468and1.00000.

Thestructurewassolved inthespacegroupP-1(#2)byIntrinsicPhasingusingtheShelXT (Sheldrick,2015)structuresolutionprogramandrefinedbyLeastSquaresusingversion2014/7ofShelXL(Sheldrick,2015). All non-hydrogen atomswere refined anisotropically. Hydrogen atom positions were calculatedgeometricallyandrefinedusingtheridingmodel.

Thereisasinglemoleculeintheasymmetricunit,whichisrepresentedbythereportedsumformula.Inotherwords:Zis2andZ'is1.

ThereisalsoanAuCl4-moleculepresent,withtwoAuatomsatspecialpositions.

There is room fora small solventmolecule,which couldpossiblybea (partial)MeOH,but couldnotberefinedassuch.ThestructurehasbeenSQUEEZEdinstead.

Page 33: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

ReflectionStatistics

Totalreflections(afterfiltering)

23132 Uniquereflections 4640

Completeness 0.991 MeanI/s 18.3 hklmaxcollected (10,10,19) hklmincollected (-10,-10,-19) hklmaxused (10,10,19) hklminused (-10,-10,0) Limdmaxcollected 100.0 Limdmincollected 0.77 dmaxused 16.11 dminused 0.83 Friedelpairs 2655 Friedelpairsmerged 1 Inconsistentequivalents 2 Rint 0.072 Rsigma 0.0409 Intensitytransformed 0 Omittedreflections 0 Omittedbyuser(OMIThkl) 0 Multiplicity (1548,1951,1350,868,538,

414,305,161,74,61,13,12) Maximummultiplicity 16

Removedsystematicabsences 0 Filteredoff(Shel/OMIT) 0

Page 34: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

Table1:FractionalAtomicCoordinates(×104)andEquivalentIsotropicDisplacementParameters(Å2×103)for2018ncs0304.Ueqisdefinedas1/3ofthetraceoftheorthogonalisedUij.Atom x y z UeqAu01 5000 5000 5000 32.18(17)Au02 2037.3(4) 7104.8(4) 7836.5(2) 31.28(16)Au03 5000 5000 10000 35.20(18)Cl04 3566(3) 4849(3) 6181.0(13) 40.9(5)Cl05 6992(3) 5863(3) 9468.3(14) 45.2(5)Cl06 5232(3) 7292(2) 5208.3(13) 42.2(5)Cl07 195(3) 9452(3) 7553.4(15) 43.3(5)Cl08 3284(3) 7423(3) 9598.5(15) 46.6(5)Cl09 154(3) 6131(3) 8378.5(15) 42.5(5)F00A 11945(6) 870(6) 4901(4) 46.0(13)F00B 9696(7) 1494(7) 4337(3) 51.1(13)F00C 10868(7) 3197(6) 4224(4) 53.4(15)N00D 3821(8) 5114(7) 8048(4) 29.6(14)N00E 6361(8) 3909(8) 7985(4) 32.7(15)N00F 3801(8) 7908(8) 7377(4) 31.4(14)C00G 5207(9) 5273(9) 7833(5) 30.4(16)C00H 3632(11) 9404(9) 7021(6) 37.4(19)C00I 4058(10) 3538(9) 8343(5) 32.3(17)C00J 5270(10) 6827(9) 7460(5) 31.6(17)C00K 8412(10) 2324(9) 5781(5) 34.3(18)C00L 6364(11) 8811(10) 6863(5) 36.1(18)C00M 6297(11) 1151(10) 8557(5) 36.6(19)C00N 10589(11) 2015(10) 4754(6) 40(2)C00O 9848(10) 2494(9) 5543(5) 35.6(18)C00P 8018(11) 3538(10) 7911(5) 36.1(19)C00Q 8570(11) 3260(9) 7030(6) 35.4(18)C00R 5632(11) 2781(9) 8292(5) 35.9(18)C00S 10644(12) 3072(10) 6016(6) 40(2)C00T 3053(12) 2711(10) 8652(5) 39.4(19)C00U 10016(11) 3461(9) 6780(6) 37(2)C00V 4880(11) 9889(10) 6760(5) 40(2)C00W 7825(10) 2728(9) 6517(6) 36.7(19)C00X 5306(13) 363(10) 8856(6) 45(2)C00Y 6541(10) 7261(10) 7196(5) 32.4(17)C00Z 3678(12) 1118(10) 8900(5) 44(2)

Page 35: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

Table2:AnisotropicDisplacementParameters(×104)2018ncs0304.Theanisotropicdisplacementfactorexponenttakestheform:-2p2[h2a*2×U11+...+2hka*×b*×U12]Atom U11 U22 U33 U23 U13 U12Au01 38.1(3) 31.2(3) 26.9(3) -2.84(19) 0.0(2) -12.0(2)Au02 32.5(2) 26.6(2) 31.6(2) -2.73(15) 0.82(15) -6.98(16)Au03 50.2(3) 28.1(3) 26.6(3) -3.45(19) 1.5(2) -12.7(2)Cl04 46.7(12) 48.6(12) 30.6(10) -8.4(8) 6.0(8) -20.0(10)Cl05 59.6(15) 42.3(12) 38.1(11) -9.0(9) 6.4(10) -22.5(11)Cl06 53.2(13) 37.2(10) 40.2(11) -7.1(8) 0.7(9) -20.0(9)Cl07 36.8(11) 31.3(11) 51.3(13) -0.9(9) 2.8(9) -1.1(8)Cl08 61.7(15) 30.7(10) 42.7(12) -4.9(9) -5.0(10) -8.9(10)Cl09 39.0(12) 39.2(11) 49.7(12) -6.2(9) 4.4(9) -15.1(9)F00A 40(3) 33(3) 53(3) -5(2) 13(2) 0(2)F00B 64(4) 49(3) 40(3) -10(2) 9(3) -17(3)F00C 63(4) 36(3) 50(3) 4(2) 22(3) -11(3)N00D 26(3) 21(3) 32(3) 1(3) 4(3) 2(3)N00E 34(4) 26(3) 32(4) -4(3) 6(3) -4(3)N00F 33(4) 28(3) 30(3) -4(3) 4(3) -8(3)C00G 31(4) 25(4) 31(4) -6(3) -2(3) -4(3)C00H 38(5) 20(4) 47(5) 0(3) -1(4) -4(3)C00I 45(5) 25(4) 28(4) -6(3) 0(3) -11(3)C00J 42(5) 26(4) 24(4) -2(3) 4(3) -9(3)C00K 35(4) 24(4) 40(4) -5(3) -3(4) -4(3)C00L 44(5) 38(4) 31(4) -7(3) 8(4) -20(4)C00M 45(5) 29(4) 28(4) -6(3) 0(4) -2(4)C00N 44(5) 27(4) 45(5) -5(4) 7(4) -6(4)C00O 37(5) 22(4) 39(5) -1(3) 7(4) -2(3)C00P 49(5) 31(4) 25(4) -11(3) 4(4) -5(4)C00Q 41(5) 25(4) 37(4) -9(3) 8(4) -6(4)C00R 46(5) 25(4) 31(4) -1(3) -1(4) -6(4)C00S 44(5) 27(4) 45(5) -2(4) 6(4) -10(4)C00T 50(5) 33(4) 36(4) -6(3) 4(4) -15(4)C00U 46(5) 21(4) 41(5) -4(3) -9(4) -8(4)C00V 54(6) 27(4) 35(5) 6(3) -1(4) -15(4)C00W 35(5) 23(4) 44(5) -5(3) 18(4) -3(3)C00X 72(7) 29(4) 35(4) -5(3) 2(4) -18(4)C00Y 30(4) 35(4) 29(4) -1(3) 2(3) -10(3)C00Z 62(7) 35(5) 40(5) -9(4) 12(5) -23(5)

Page 36: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

Table3:BondLengthsinÅfor2018ncs0304.Atom Atom Length/ÅAu01 Cl04 2.286(2)Au01 Cl041 2.286(2)Au01 Cl061 2.285(2)Au01 Cl06 2.285(2)Au02 Cl07 2.252(2)Au02 Cl09 2.253(2)Au02 N00D 2.006(6)Au02 N00F 2.034(7)Au03 Cl05 2.279(2)Au03 Cl052 2.279(2)Au03 Cl08 2.272(2)Au03 Cl082 2.272(2)F00A C00N 1.340(10)F00B C00N 1.347(11)F00C C00N 1.340(10)N00D C00G 1.342(11)N00D C00I 1.389(10)N00E C00G 1.344(10)N00E C00P 1.444(12)N00E C00R 1.409(11)N00F C00H 1.352(11)N00F C00J 1.383(11)

Atom Atom Length/ÅC00G C00J 1.463(11)C00H C00V 1.372(13)C00I C00R 1.386(13)C00I C00T 1.391(12)C00J C00Y 1.370(12)C00K C00O 1.397(12)C00K C00W 1.365(12)C00L C00V 1.394(13)C00L C00Y 1.388(12)C00M C00R 1.416(11)C00M C00X 1.353(14)C00N C00O 1.505(12)C00O C00S 1.376(13)C00P C00Q 1.546(11)C00Q C00U 1.420(13)C00Q C00W 1.363(13)C00S C00U 1.412(13)C00T C00Z 1.379(12)C00X C00Z 1.427(14)–––– 11-x,1-y,1-z;21-x,1-y,2-z

Table4:BondAnglesin°for2018ncs0304.Atom Atom Atom Angle/°Cl04 Au01 Cl041 180.0Cl061 Au01 Cl041 90.30(8)Cl061 Au01 Cl04 89.70(8)Cl06 Au01 Cl04 90.30(8)Cl06 Au01 Cl041 89.71(8)Cl06 Au01 Cl061 180.0Cl07 Au02 Cl09 87.34(9)N00D Au02 Cl07 174.7(2)N00D Au02 Cl09 97.9(2)N00D Au02 N00F 79.9(3)N00F Au02 Cl07 94.8(2)N00F Au02 Cl09 177.6(2)Cl05 Au03 Cl052 180.0Cl08 Au03 Cl05 90.62(9)Cl082 Au03 Cl05 89.38(9)Cl082 Au03 Cl052 90.62(9)Cl08 Au03 Cl052 89.38(9)Cl082 Au03 Cl08 180.00(13)C00G N00D Au02 114.7(5)C00G N00D C00I 107.2(6)C00I N00D Au02 138.1(6)C00G N00E C00P 131.6(7)C00G N00E C00R 105.2(7)C00R N00E C00P 123.1(7)C00H N00F Au02 124.7(6)C00H N00F C00J 119.1(7)C00J N00F Au02 116.2(5)N00D C00G N00E 112.4(7)N00D C00G C00J 118.2(7)N00E C00G C00J 129.4(8)N00F C00H C00V 121.8(8)N00D C00I C00T 132.3(8)C00R C00I N00D 106.8(7)

Atom Atom Atom Angle/°C00R C00I C00T 120.9(8)N00F C00J C00G 110.9(7)C00Y C00J N00F 120.7(7)C00Y C00J C00G 128.3(8)C00W C00K C00O 117.4(8)C00Y C00L C00V 119.2(8)C00X C00M C00R 116.2(9)F00A C00N F00B 106.8(7)F00A C00N F00C 106.9(7)F00A C00N C00O 111.8(8)F00B C00N C00O 112.4(8)F00C C00N F00B 106.1(8)F00C C00N C00O 112.4(7)C00K C00O C00N 120.2(8)C00S C00O C00K 122.1(8)C00S C00O C00N 117.7(8)N00E C00P C00Q 111.6(7)C00U C00Q C00P 116.6(8)C00W C00Q C00P 124.4(8)C00W C00Q C00U 118.8(8)N00E C00R C00M 129.3(8)C00I C00R N00E 108.3(7)C00I C00R C00M 122.3(8)C00O C00S C00U 119.2(9)C00Z C00T C00I 117.6(9)C00S C00U C00Q 118.7(8)C00H C00V C00L 119.2(8)C00Q C00W C00K 123.7(8)C00M C00X C00Z 122.3(8)C00J C00Y C00L 119.8(8)C00T C00Z C00X 120.7(9)–––– 11-x,1-y,1-z;21-x,1-y,2-z

Page 37: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

Table5:TorsionAnglesin°for2018ncs0304.Atom Atom Atom Atom Angle/°Au02 N00D C00G N00E -179.9(5)Au02 N00D C00G C00J -1.4(9)Au02 N00D C00I C00R 177.6(6)Au02 N00D C00I C00T -2.8(15)Au02 N00F C00H C00V 176.6(7)Au02 N00F C00J C00G 3.2(8)Au02 N00F C00J C00Y -177.8(6)F00A C00N C00O C00K -118.1(8)F00A C00N C00O C00S 60.9(10)F00B C00N C00O C00K 2.0(11)F00B C00N C00O C00S -179.0(7)F00C C00N C00O C00K 121.6(9)F00C C00N C00O C00S -59.4(11)N00D C00G C00J N00F -1.2(10)N00D C00G C00J C00Y 179.9(8)N00D C00I C00R N00E 1.6(9)N00D C00I C00R C00M 178.9(7)N00D C00I C00T C00Z -179.9(8)N00E C00G C00J N00F 176.9(8)N00E C00G C00J C00Y -1.9(14)N00E C00P C00Q C00U 157.3(7)N00E C00P C00Q C00W -27.9(11)N00F C00H C00V C00L 0.1(14)N00F C00J C00Y C00L 1.9(12)C00G N00D C00I C00R -0.1(9)C00G N00D C00I C00T 179.5(9)C00G N00E C00P C00Q -88.2(10)C00G N00E C00R C00I -2.4(9)C00G N00E C00R C00M -179.5(8)C00G C00J C00Y C00L -179.3(8)C00H N00F C00J C00G -178.2(7)C00H N00F C00J C00Y 0.8(12)C00I N00D C00G N00E -1.6(9)C00I N00D C00G C00J 176.9(7)C00I C00T C00Z C00X 1.4(13)C00J N00F C00H C00V -1.8(13)C00K C00O C00S C00U 2.1(12)C00M C00X C00Z C00T -1.6(14)C00N C00O C00S C00U -176.9(8)C00O C00K C00W C00Q -1.0(12)C00O C00S C00U C00Q -0.8(12)C00P N00E C00G N00D -175.1(8)C00P N00E C00G C00J 6.7(14)C00P N00E C00R C00I 175.4(7)C00P N00E C00R C00M -1.7(13)C00P C00Q C00U C00S 173.8(7)C00P C00Q C00W C00K -172.5(8)C00R N00E C00G N00D 2.5(9)C00R N00E C00G C00J -175.8(8)C00R N00E C00P C00Q 94.6(9)C00R C00I C00T C00Z -0.3(12)C00R C00M C00X C00Z 0.5(13)C00T C00I C00R N00E -178.1(7)C00T C00I C00R C00M -0.7(13)C00U C00Q C00W C00K 2.2(13)C00V C00L C00Y C00J -3.6(13)C00W C00K C00O C00N 177.7(8)C00W C00K C00O C00S -1.2(12)

Page 38: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

Atom Atom Atom Atom Angle/°C00W C00Q C00U C00S -1.2(12)C00X C00M C00R N00E 177.3(9)C00X C00M C00R C00I 0.6(12)C00Y C00L C00V C00H 2.6(13)

Table6:HydrogenFractionalAtomicCoordinates(×104)andEquivalentIsotropicDisplacementParameters(Å2×103)for2018ncs0304.Ueqisdefinedas1/3ofthetraceoftheorthogonalisedUij.Atom x y z UeqH00H 2621 10140 6949 45H00K 7865 1943 5443 41H00L 7244 9134 6708 43H00M 7379 639 8525 44H00A 8529 2590 8323 43H00B 8327 4405 8036 43H00S 11603 3209 5831 48H00T 1973 3226 8691 47H00U 10552 3848 7121 44H00V 4733 10947 6513 48H00W 6841 2632 6681 44H00X 5707 -733 9045 54H00Y 7542 6504 7241 39H00Z 3019 518 9101 53

Table7:Solventmasking(Olex2)informationfor2018ncs0304.No x y z V e Content1 0.000 0.000 0.000 87.7 6.0 ?

Citations

CrysAlisProSoftwareSystem,RigakuOxfordDiffraction,(2018).

O.V.DolomanovandL.J.BourhisandR.J.GildeaandJ.A.K.HowardandH.Puschmann,Olex2:Acompletestructuresolution,refinementandanalysisprogram,J.Appl.Cryst.,(2009),42,339-341.

Sheldrick,G.M.,CrystalstructurerefinementwithShelXL,ActaCryst.,(2015),C27,3-8.

Sheldrick,G.M.,ShelXT-Integratedspace-groupandcrystal-structuredetermination,ActaCryst.,(2015),A71,3-8.

Page 39: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin
Page 40: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin
Page 41: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

2018ncs0303

Submittedby: ProfCasiniSolvedby: WimTKloosterSampleID: 7

CrystalDataandExperimental

Figure S63: Thermal ellipsoids drawn at the 50%probabilitylevel.

Experimental.A suitableyellowplate-shaped crystal of2018ncs0303 (0.080×0.050×0.020)mm3 was selectedandmounted on a MITIGEN holder on a Rigaku 007HFdiffractometer equipped with Varimax confocal mirrorsand an AFC11 goniometer and HyPix 6000HE detector.The crystal was kept at T = 100.00(10)K during datacollection. Using Olex2 (Dolomanov et al., 2009), thestructurewas solvedwith theShelXT (Sheldrick, 2015)structure solution program, using the Intrinsic Phasingsolution method. The model was refined with version2014/7ofShelXL (Sheldrick,2015)usingLeastSquaresminimisation.

Crystal Data. C19H14AuCl3FN3, Mr= 606.65, monoclinic,P21/n(No.14),a=12.19750(10)Å,b=9.77810(10)Å,c=17.08670(10)Å, b= 108.9480(10)°, a= g= 90°, V=1927.48(3)Å3,T=100(2)K,Z=4,Z'=1,µ(CuKa)=18.336mm-1, 34653 reflections measured, 3523 unique (Rint=0.0329)whichwereusedinallcalculations.ThefinalwR2

was0.0440(alldata)andR1was0.0167(I>2(I)).

Compound 2018ncs0303 Formula C19H14AuCl3FN3 Dcalc./gcm-3 2.091 µ/mm-1 18.336 FormulaWeight 606.65 Colour yellow Shape plate Size/mm3 0.080×0.050×0.020 T/K 100(2) CrystalSystem monoclinic SpaceGroup P21/n a/Å 12.19750(10) b/Å 9.77810(10) c/Å 17.08670(10) a/° 90 b/° 108.9480(10) g/° 90 V/Å3 1927.48(3) Z 4 Z' 1 Wavelength/Å 1.54184 Radiationtype CuKa Qmin/° 3.919 Qmax/° 68.251 MeasuredRefl. 34653 IndependentRefl. 3523 ReflectionsUsed 3499 Rint 0.0329 Parameters 244 Restraints 0 LargestPeak 0.623 DeepestHole -0.726 GooF 1.086 wR2(alldata) 0.0440 wR2 0.0439 R1(alldata) 0.0169 R1 0.0167

Page 42: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

StructureQualityIndicators

Reflections: Refinement:

Ayellowplate-shapedcrystalwithdimensions0.080×0.050×0.020mm3wasmountedonaMITIGENholder.X-raydiffractiondatawerecollectedusingaRigaku007HFdiffractometerequippedwithVarimaxconfocalmirrorsandanAFC11goniometerandHyPix6000HEdetector,andequippedwithanOxfordCryosystemslow-temperaturedevice,operatingatT=100.00(10)K.

Dataweremeasuredusingwscansof0.5°perframefor1.0susingCuKaradiation(Rotating-anodeX-raytube,40kV,30mA).ThetotalnumberofrunsandimageswasbasedonthestrategycalculationfromtheprogramCrysAlisPro(Rigaku,V1.171.39.46,2018).ThemaximumresolutionachievedwasQ=68.251°.

CellparameterswereretrievedusingtheCrysAlisPro(Rigaku,V1.171.39.46,2018)softwareandrefinedusingCrysAlisPro(Rigaku,V1.171.39.46,2018)on26320reflections,76%oftheobservedreflections.

DatareductionwasperformedusingtheCrysAlisPro(Rigaku,V1.171.39.46,2018)softwarewhichcorrectsforLorentzpolarisation.Thefinalcompletenessis99.90%outto68.251°inQ.

A multi-scan absorption correction was performed using CrysAlisPro 1.171.39.46 (Rigaku OxfordDiffraction, 2018) Empirical absorption correction using spherical harmonics, implemented in SCALE3ABSPACKscalingalgorithm.Theabsorptioncoefficientµofthismaterialis18.336mm-1atthiswavelength(l=1.54184Å)andtheminimumandmaximumtransmissionsare0.44132and1.00000.

ThestructurewassolvedinthespacegroupP21/n(#14)byIntrinsicPhasingusingtheShelXT(Sheldrick,2015)structuresolutionprogramandrefinedbyLeastSquaresusingversion2014/7ofShelXL(Sheldrick,2015). All non-hydrogen atomswere refined anisotropically. Hydrogen atom positions were calculatedgeometricallyandrefinedusingtheridingmodel.

Thereisasinglemoleculeintheasymmetricunit,whichisrepresentedbythereportedsumformula.Inotherwords:Zis4andZ'is1.

Page 43: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

ReflectionStatistics

Totalreflections(afterfiltering)

35917 Uniquereflections 3523

Completeness 0.999 MeanI/s 54.85 hklmaxcollected (14,11,20) hklmincollected (-14,-11,-20) hklmaxused (13,11,20) hklminused (-14,0,0) Limdmaxcollected 100.0 Limdmincollected 0.77 dmaxused 16.16 dminused 0.83 Friedelpairs 4978 Friedelpairsmerged 1 Inconsistentequivalents 0 Rint 0.0329 Rsigma 0.0143 Intensitytransformed 0 Omittedreflections 0 Omittedbyuser(OMIThkl) 0 Multiplicity (2807,3248,2021,1524,

1076,592,414,170,79,51,4) Maximummultiplicity 26

Removedsystematicabsences 1264 Filteredoff(Shel/OMIT) 0

Page 44: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

Table1:FractionalAtomicCoordinates(×104)andEquivalentIsotropicDisplacementParameters(Å2×103)for2018ncs0303.Ueqisdefinedas1/3ofthetraceoftheorthogonalisedUij.Atom x y z UeqAu1 7564.7(2) 1459.3(2) 5627.6(2) 17.11(5)Cl1 8834.0(6) 1625.2(7) 4903.3(4) 23.57(14)Cl2 8494.3(6) -466.6(6) 6241.8(4) 24.44(14)Cl3 6216.1(6) 1236.9(7) 6290.3(4) 22.30(13)F1 8554.0(16) 8147.3(18) 2035.5(11) 32.6(4)N1 6755.9(19) 3168(2) 5055.3(13) 17.8(4)N2 6494.9(18) 5305(2) 4616.4(12) 16.9(4)N3 8589.4(19) 4009(2) 6452.0(13) 20.5(4)C1 5657(2) 3243(3) 4465.4(15) 18.2(5)C2 4822(2) 2245(3) 4147.2(16) 22.1(5)C3 3807(2) 2665(3) 3554.6(16) 23.5(6)C4 3629(2) 4027(3) 3290.2(16) 23.8(6)C5 4461(2) 5029(3) 3603.2(16) 21.6(5)C6 5482(2) 4602(3) 4193.9(15) 17.8(5)C7 7232(2) 4413(3) 5134.4(15) 18.2(5)C8 8367(2) 4735(3) 5748.1(15) 18.4(5)C9 9128(2) 5680(3) 5614.1(17) 25.2(6)C10 10147(3) 5942(3) 6254.9(19) 31.4(7)C11 10367(3) 5249(3) 6991.1(17) 27.9(6)C12 9575(2) 4279(3) 7053.3(17) 24.0(6)C13 6654(2) 6789(3) 4524.1(16) 18.5(5)C14 7165(2) 7130(3) 3848.8(15) 17.9(5)C15 6775(3) 6491(3) 3077.6(17) 21.0(6)C16 7239(2) 6841(3) 2463.5(17) 23.7(6)C17 8094(2) 7825(3) 2637.1(17) 22.8(6)C18 8507(3) 8470(3) 3387.1(18) 24.4(6)C19 8027(2) 8116(3) 3996.5(16) 21.5(5)

Table2:AnisotropicDisplacementParameters(×104)2018ncs0303.Theanisotropicdisplacementfactorexponenttakestheform:-2p2[h2a*2×U11+...+2hka*×b*×U12]Atom U11 U22 U33 U23 U13 U12Au1 19.58(7) 16.47(7) 14.74(7) 1.17(3) 4.82(5) -2.22(4)Cl1 25.3(3) 25.6(3) 22.6(3) 1.9(2) 11.6(3) -0.7(2)Cl2 28.3(3) 20.5(3) 24.7(3) 4.7(2) 9.0(3) 2.0(2)Cl3 23.8(3) 22.8(3) 22.0(3) 4.2(2) 9.7(3) -1.5(2)F1 44.0(10) 32.2(9) 30.9(9) 6.7(7) 24.7(8) 1.2(8)N1 19.2(11) 17.7(10) 15.9(10) 0.8(9) 4.8(8) -3.3(9)N2 18.7(10) 16.9(10) 14.8(10) 1.6(8) 5.2(8) -1.8(8)N3 21.7(11) 20.3(11) 18.6(11) 2.1(9) 5.1(9) -1.3(9)C1 19.4(13) 22.7(12) 13.2(12) -2.3(10) 6.4(10) -2.0(10)C2 24.6(13) 25.8(14) 18.2(12) -1.9(11) 10.0(11) -5.4(11)C3 22.0(13) 31.4(15) 18.5(13) -5.8(11) 8.7(11) -10.0(11)C4 18.5(13) 35.6(16) 16.6(12) -3.4(11) 4.8(10) 0.9(12)C5 22.9(13) 25.7(14) 17.9(12) 1.0(10) 9.1(10) 1.4(11)C6 19.4(12) 22.6(13) 12.7(11) -3.0(10) 7.1(10) -4.2(10)C7 19.7(12) 21.2(13) 14.5(11) 1.5(10) 6.6(10) -1.0(10)C8 19.7(12) 17.1(12) 17.4(12) 0.7(10) 4.6(10) -1.1(10)C9 23.7(14) 29.0(15) 20.5(13) 7.3(11) 3.7(11) -4.6(11)C10 28.1(15) 31.6(16) 30.0(15) 8.4(13) 3.1(12) -10.5(13)C11 26.1(14) 29.7(15) 22.7(14) 2.0(11) 0.6(11) -4.2(12)C12 26.0(14) 26.2(14) 18.1(13) 3.8(11) 4.9(11) 0.6(11)C13 23.6(13) 15.4(12) 16.8(12) -0.3(10) 7.1(10) -1.7(10)C14 21.3(12) 15.7(12) 17.1(12) 3.8(9) 6.9(10) 2.2(10)C15 26.1(14) 18.1(14) 19.2(14) 1.2(9) 8.1(12) -0.3(10)C16 34.0(16) 20.1(13) 17.9(13) 1.0(11) 9.6(11) 2.8(12)C17 28.8(14) 21.9(13) 22.9(13) 8.1(11) 15.4(11) 5.9(11)C18 22.8(14) 21.6(14) 28.1(15) 7.5(10) 7.3(12) -0.8(10)C19 24.8(14) 20.0(13) 18.6(13) 1.9(10) 5.4(11) 0.6(11)

Page 45: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

Table3:BondLengthsinÅfor2018ncs0303.Atom Atom Length/ÅAu1 Cl1 2.2802(6)Au1 Cl2 2.2718(6)Au1 Cl3 2.2902(6)Au1 N1 2.024(2)F1 C17 1.358(3)N1 C1 1.393(3)N1 C7 1.337(3)N2 C6 1.393(3)N2 C7 1.355(3)N2 C13 1.479(3)N3 C8 1.347(3)N3 C12 1.330(4)C1 C2 1.388(4)C1 C6 1.401(4)C2 C3 1.383(4)

Atom Atom Length/ÅC3 C4 1.400(4)C4 C5 1.387(4)C5 C6 1.388(4)C7 C8 1.474(4)C8 C9 1.380(4)C9 C10 1.388(4)C10 C11 1.376(4)C11 C12 1.383(4)C13 C14 1.516(3)C14 C15 1.395(4)C14 C19 1.387(4)C15 C16 1.387(4)C16 C17 1.379(4)C17 C18 1.369(4)C18 C19 1.394(4)

Table4:BondAnglesin°for2018ncs0303.Atom Atom Atom Angle/°Cl1 Au1 Cl3 176.75(2)Cl2 Au1 Cl1 89.13(2)Cl2 Au1 Cl3 91.36(2)N1 Au1 Cl1 89.39(6)N1 Au1 Cl2 178.43(6)N1 Au1 Cl3 90.09(6)C1 N1 Au1 126.63(18)C7 N1 Au1 125.13(17)C7 N1 C1 108.0(2)C6 N2 C13 123.6(2)C7 N2 C6 108.1(2)C7 N2 C13 128.2(2)C12 N3 C8 117.0(2)N1 C1 C6 107.3(2)C2 C1 N1 131.1(3)C2 C1 C6 121.6(2)C3 C2 C1 116.5(3)C2 C3 C4 121.8(2)C5 C4 C3 122.0(2)C4 C5 C6 116.0(3)N2 C6 C1 106.4(2)C5 C6 N2 131.6(2)

Atom Atom Atom Angle/°C5 C6 C1 122.1(2)N1 C7 N2 110.2(2)N1 C7 C8 122.9(2)N2 C7 C8 126.8(2)N3 C8 C7 113.1(2)N3 C8 C9 123.4(2)C9 C8 C7 123.5(2)C8 C9 C10 118.1(2)C11 C10 C9 119.3(3)C10 C11 C12 118.3(3)N3 C12 C11 123.8(3)N2 C13 C14 113.4(2)C15 C14 C13 121.5(2)C19 C14 C13 119.3(2)C19 C14 C15 119.3(2)C16 C15 C14 120.4(3)C17 C16 C15 118.4(3)F1 C17 C16 117.9(2)F1 C17 C18 119.0(3)C18 C17 C16 123.0(2)C17 C18 C19 118.0(3)C14 C19 C18 120.9(3)

Page 46: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

Table5:TorsionAnglesin°for2018ncs0303.Atom Atom Atom Atom Angle/°Au1 N1 C1 C2 3.6(4)Au1 N1 C1 C6 -

175.69(16)Au1 N1 C7 N2 174.79(16)Au1 N1 C7 C8 -9.0(3)F1 C17 C18 C19 -179.6(2)N1 C1 C2 C3 -179.7(3)N1 C1 C6 N2 1.3(3)N1 C1 C6 C5 -179.7(2)N1 C7 C8 N3 -32.8(3)N1 C7 C8 C9 146.9(3)N2 C7 C8 N3 142.7(3)N2 C7 C8 C9 -37.5(4)N2 C13 C14 C15 44.0(3)N2 C13 C14 C19 -137.0(2)N3 C8 C9 C10 -3.4(4)C1 N1 C7 N2 -0.4(3)C1 N1 C7 C8 175.8(2)C1 C2 C3 C4 -0.2(4)C2 C1 C6 N2 -178.0(2)C2 C1 C6 C5 1.0(4)C2 C3 C4 C5 0.4(4)C3 C4 C5 C6 0.1(4)C4 C5 C6 N2 178.0(2)C4 C5 C6 C1 -0.7(4)C6 N2 C7 N1 1.3(3)C6 N2 C7 C8 -174.8(2)C6 N2 C13 C14 -90.7(3)C6 C1 C2 C3 -0.5(4)C7 N1 C1 C2 178.7(3)C7 N1 C1 C6 -0.6(3)C7 N2 C6 C1 -1.6(3)C7 N2 C6 C5 179.6(3)C7 N2 C13 C14 93.4(3)C7 C8 C9 C10 176.9(3)C8 N3 C12 C11 -0.1(4)C8 C9 C10 C11 0.6(5)C9 C10 C11 C12 2.1(5)C10 C11 C12 N3 -2.4(5)C12 N3 C8 C7 -177.2(2)C12 N3 C8 C9 3.1(4)C13 N2 C6 C1 -178.2(2)C13 N2 C6 C5 3.0(4)C13 N2 C7 N1 177.7(2)C13 N2 C7 C8 1.6(4)C13 C14 C15 C16 178.6(2)C13 C14 C19 C18 -179.1(2)C14 C15 C16 C17 0.4(4)C15 C14 C19 C18 -0.2(4)C15 C16 C17 F1 179.1(2)C15 C16 C17 C18 0.0(4)C16 C17 C18 C19 -0.5(4)C17 C18 C19 C14 0.6(4)C19 C14 C15 C16 -0.3(4)

Page 47: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin

Table6:HydrogenFractionalAtomicCoordinates(×104)andEquivalentIsotropicDisplacementParameters(Å2×103)for2018ncs0303.Ueqisdefinedas1/3ofthetraceoftheorthogonalisedUij.Atom x y z UeqH2 4941 1321 4327 27H3 3215 2012 3320 28H4 2917 4272 2884 29H5 4339 5953 3424 26H9 8959 6138 5098 30H10 10687 6593 6186 38H11 11047 5432 7445 34H12 9744 3777 7555 29H13A 7170 7156 5056 22H13B 5894 7250 4399 22H15 6189 5811 2972 25H16 6973 6414 1936 28H18 9102 9139 3489 29H19 8293 8555 4520 26

Citations

CrysAlisProSoftwareSystem,RigakuOxfordDiffraction,(2018).

O.V.DolomanovandL.J.BourhisandR.J.GildeaandJ.A.K.HowardandH.Puschmann,Olex2:Acompletestructuresolution,refinementandanalysisprogram,J.Appl.Cryst.,(2009),42,339-341.

Sheldrick,G.M.,CrystalstructurerefinementwithShelXL,ActaCryst.,(2015),C27,3-8.

Sheldrick,G.M.,ShelXT-Integratedspace-groupandcrystal-structuredetermination,ActaCryst.,(2015),A71,3-8.

Page 48: Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin inhibitors … · 2020. 1. 23. · 1 Supporting Information Gold(III) pyridine-benzimidazole complexes as aquaglyceroporin